Sara Guerrisi

Clinical and genetic analysis of patients with segmental overgrowth features and somatic mammalian target of rapamycin (mTOR) pathway disruption: Possible novel clinical issues

F. Zara, V. Capra, M. Iacomino, 2022, Birth defects research.

Moyamoya Vasculopathy in Neurofibromatosis Type 1 Pediatric Patients: The Role of Rare Variants of RNF213

F. Zara, V. Capra, I. Schiavetti, 2023, Cancers.

Somatic Double Inactivation of NF1 Associated with NF1-Related Pectus Excavatum Deformity

P. Striano, F. Zara, D. Vozzi, 2023, Human Mutation.

Hydranencephaly in CENPJ-related Seckel syndrome.

P. Striano, A. Coppola, L. Ugga, 2022, European journal of medical genetics.